SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040804
Filing Date
2023-11-14
Accepted
2023-11-14 09:00:39
Documents
75
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1573999
2 ex31-1.htm EX-31.1 20543
3 ex31-2.htm EX-31.2 20614
4 ex32-1.htm EX-32.1 7639
5 ex32-2.htm EX-32.2 7801
  Complete submission text file 0001493152-23-040804.txt   8699198

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20230930.xsd EX-101.SCH 67596
7 XBRL CALCULATION FILE otlc-20230930_cal.xml EX-101.CAL 51476
8 XBRL DEFINITION FILE otlc-20230930_def.xml EX-101.DEF 357798
9 XBRL LABEL FILE otlc-20230930_lab.xml EX-101.LAB 472169
10 XBRL PRESENTATION FILE otlc-20230930_pre.xml EX-101.PRE 421041
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1375857
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 231401912
SIC: 2834 Pharmaceutical Preparations